Wednesday Aug 27
Navidea Biopharmaceuticals Short Interest Up 0.3% in August
Navidea Biopharmaceuticals was the recipient of a significant growth in short interest in August.
Navidea Biopharmaceuticals, Inc's (NAVB) CEO Michael Goldberg on Q2...
Welcome to the Navidea Biopharmaceuticals Second Quarter 2014 earnings call. My name is Larissa, and I'll be your operator for today's call.
Navidea Biopharmaceuticals Announces Second Quarter 2014 Financial...
Navidea Biopharmaceuticals, Inc. , a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced financial results and business highlights for the second quarter and first half of 2014.
Customer Interaction Solutions
Navidea Biopharmaceuticals to Announce Second Quarter 2014 Financial Results on August 6, 2014
Navidea Biopharmaceuticals, Inc. , a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that the Company will report its financial results for the second quarter 2014, on Wednesday, August 6, 2014 before the market opens.